Rx Bandz

𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗘𝗺𝗲𝗿𝗴𝗲𝗻𝗰𝘆 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 Join us on 𝗠𝗮𝘆 𝟮𝟭 from 12:00 – 1:00 PM PST for a powerful WLO Thought Leader session with Jessica Walsh, Founder & CEO of Rx Bandz. With decades of entrepreneurial experience and a mission to save lives, Jessica will share the story behind MiniJect—the world’s smallest auto-injector—and how Rx Bandz is transforming drug delivery for patients worldwide. This is a must-attend for those passionate about medtech, innovation, and purpose-driven leadership. 𝗦𝗽𝗼𝘁𝘀 𝗮𝗿𝗲 𝗹𝗶𝗺𝗶𝘁𝗲𝗱—𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼𝗱𝗮𝘆: https://lnkd.in/gEwUjS8s #WLO #ThoughtLeadership #MedTech #InnovationWithPurpose #RxBandz

What an incredible experience at BioNJ’s 15th Annual Partnering Conference! The energy, talent, and innovation in the room were nothing short of inspiring. With over 50 companies presenting, the level of innovation and dedication to transforming healthcare was truly remarkable. I was honored to present Rx Bandz’s mission, disruptive auto-injector platform technology, and investment opportunity in front of a panel of esteemed investors. I'm incredibly proud to share that we were awarded, 🏆 Best Company Presentation 🏆 Most Inspiring Presentation These awards are a testament to the brilliance and tireless dedication of the entire Rx Bandz team. Every step forward is powered by their perseverance, ingenuity, and unwavering commitment to get our auto-injectors in the hands of those who need it most and save lives around the world. I’m deeply grateful to be building this future with all of you. Special thanks to Stephen Harhen, Harsha Murthy, Grant Miller, Thomas Gardner, Yosyong Surakitbanharn, Chris Taylor, MBA, Myrna Walsh, Sean Hollonbeck Krishnamurthy Govindaraj, MS, PhD, MBA and the rest of our Rx Bandz team. A heartfelt thank you to the BioNJ team, their sponsors and everyone who made the event so impactful. #BioPartnering2025 #BioNJEntrepreneurs

𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗘𝗺𝗲𝗿𝗴𝗲𝗻𝗰𝘆 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 Join us on 𝗠𝗮𝘆 𝟮𝟭 from 12:00 – 1:00 PM PST for a powerful WLO Thought Leader session with Jessica Walsh, Founder & CEO of Rx Bandz. With decades of entrepreneurial experience and a mission to save lives, Jessica will share the story behind MiniJect—the world’s smallest auto-injector—and how Rx Bandz is transforming drug delivery for patients worldwide. This is a must-attend for those passionate about medtech, innovation, and purpose-driven leadership. 𝗦𝗽𝗼𝘁𝘀 𝗮𝗿𝗲 𝗹𝗶𝗺𝗶𝘁𝗲𝗱—𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼𝗱𝗮𝘆: https://lnkd.in/gEwUjS8s #WLO #ThoughtLeadership #MedTech #InnovationWithPurpose #RxBandz

Grateful to have represented Rx Bandz at the JP Morgan Healthcare Leadership Summit! It was inspiring to connect with such an incredible group of healthcare leaders, investors, and innovators. Proud to be part of this dynamic community driving meaningful change in healthcare. A special thank you to Stony Lonesome Group LLC and our fellow portfolio companies. It’s always great to collaborate and share this journey together!

The team at Rx Bandz recently reached out to share an update on their continued progress in emergency medical technology. Rx Bandz is a privately held biotech company developing a platform of auto-injectors including, the world’s smallest, ruggedized, and patient-friendly auto-injector. Designed for both military and civilian use, MiniJect delivers a range of emergency and specialty medications such as epinephrine, ketamine, and hydromorphone, antibiotics and tranexamic acid, with speed, reliability, and ease. The Rx Bandz platform of auto-injectors are compact, waterproof, cost-effective, and simple to operate even under extreme conditions. MiniJect is engineered to address adherence challenges seen with current solutions and supports drug-specific customization to deliver more challenging formulations such as high viscosity GLP-1 and vaccines. The platform is being advanced through the FDA’s 505(b)(2) pathway and is built to meet both FDA and military ruggedization standards. Rx Bandz has secured $36.5 million in combined dilutive and non-dilutive funding, including 15 Department of Defense contracts. The company is addressing a significant unmet need in the $120 billion auto-injector market and is projecting $282 million in revenue following FDA approval. CEO Jessica Walsh and Rx Bandz’ world-class team is committed to making life-saving treatment more accessible for both the armed forces and civilian populations. To learn more or connect directly, reach out to Myrna@RxBandz.com.